aztreonam has been researched along with Ear Diseases in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Ear Diseases: Pathological processes of the ear, the hearing, and the equilibrium system of the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam (SQ 26,776) was given subcutaneously to three groups of neonatal rats at daily doses of 150, 600, and 2400 mg/kg from postnatal Days 10 through 16." | 1.27 | Ototoxicity of subcutaneously administered aztreonam in neonatal rats. ( DePaoli, A; Keim, GR; Myhre, JL, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Myhre, JL | 1 |
| DePaoli, A | 1 |
| Keim, GR | 1 |
1 other study available for aztreonam and Ear Diseases
| Article | Year |
|---|---|
Ototoxicity of subcutaneously administered aztreonam in neonatal rats.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Aztreonam; Body Weight; Ear Diseases; Female; Inje | 1985 |